Networked Scanners

WHITE PAPERS AND CASE STUDIES

• Choosing The Right Fit For Your Business: Anatomy Of A Cash Drawer

  The cash drawer has been a key component of the retail business for as long as people have exchanged money for goods. If you accept currency, you need the best cash drawer, but choosing the right drawer and till solution requires planning, consideration, and a little research.

• Fujirebio Increases Study Agility By Streamlining Clinical Operations And Data Management Process

  Fujirebio’s fast-growing U.S. Clinical R&D team was preparing for shorter studies with higher complexity. Traditional methods using paper and spreadsheet trackers were no longer adequate to meet quality goals. Learn how the group increased its agility and readiness with LifeSphere Clinical EDC and CTMS tools.

• How Actigraphy Is Clearing Operational Barriers To Decentralized Trials

  In this white paper, explore why sponsors are turning to proven systems for collecting real-world data to support their DCTs.

• Partnering On An Innovative Hydrogel-Based Treatment For Glioblastoma

  Treatments for glioblastoma multiforme (GBM) are in high demand. Learn more about the new possibilities for increased dosing and diffusion capabilities offered by nanoformed APIs.

• Material Selection For Medical Device Manufacturability

  Choosing the right material in the earliest stages of research & development can make all the difference in beating your competitors to market and avoid increased project costs, development delays and manufacturing setbacks.

• Antibody Drug Conjugates: Global Trial Landscape - Focus On Asia Pacific

  Gain a better understanding of the global clinical trial landscape of antibody drug conjugates (ADCs) and their trends in the Asia Pacific.

• Centrifuges Transforming Biopharmaceutical Development And Manufacturing

  Single-use centrifuges have the potential to become the new bioprocessing standard, helping manufacturers meet the need for innovative production methods when facing emerging modalities and next-generation biotherapeutics at scale.

• The Role Of The Technical Transfer Executive Sponsor

  Explore the importance of understanding a CDMO’s flexibility and culture, models and scale of equipment, technical capabilities, regulatory support, quality system, and executive sponsorship model.

• ICH And USP <1220>: Implementing A Quality By Design Analytical Framework

  The ICH and the USP are currently finalizing draft guidelines that describe a new paradigm for analytical development based on the QbD approach used for development.

• Isolator Vs. Optocoupler Technology

  While optocouplers have been the dominant signal isolation solution for a long time, a new breed of higher-performance CMOS isolator solutions will ultimately out-mode the venerable optocoupler.

• Oncolytic Virus Therapies – Global Clinical Trial Landscape - Focus On Asia Pacific

  Explore the global landscape of oncolytic virus clinical trials, with a particular focus on trends in the Asia Pacific region.

• Streamlining Study Start-Up For Accelerated Drug Development

  Discover how we accelerated a Phase 1 study’s start-up time by 70%! This case study shares insights on streamlining communication, strategic planning, and more.